EU Clinical Materials Valuation and HTS Coding

EU Clinical material imports are taxed differently depending on the EU country’s regulations.

Trial sponsors looking to import clinical materials into the EU need to declare accurate clinical material valuations (CMV) to avoid fixed penalties, the destruction of material, and shipment delays. 

In this water cooler chat, Gavin Morgan, PCI’s Senior Manager of Global Logistics will give a brief overview of the six methods used to calculate clinical material valuation. He will also focus on the impact of using these valuations and HTCs in the EU and the UK including:

  • VAT implications in the EU and the UK
  • The delays, material destruction, and fixed penalty notices that can result from inaccurate CMVs
  • What CMV information is shared across the EU and the UK.

Listen to the audio here:

EU Information Required – Clinical Materials Valuation & HTS Coding for Clinical Materials (mp3)

We provide a complete range of clinical trial services and we are committed to supporting clients at every stage of the clinical cycle, delivering best-in-class services efficiently and effectively.

Find out more about our clinical trial services.


Our dedicated team of specialists will be happy to discuss any of your clinical trial service needs. Contact us on +1 779-208-1819 (US) or +44 1495 711 222 (UK/EU) or email talkfuture@pci.com